Natural Capsules Limited has completed the electronic dispatch of its Annual Report for the financial year 2025-26 on July 17, 2026. The company informed the exchanges that the Notice of the 33rd Annual General Meeting (AGM) and the Integrated Annual Report are available on its website and the websites of the stock exchanges. The AGM is scheduled to be held on Wednesday, August 12, 2026, at 12:00 PM IST via Video Conferencing (VC) or Other Audio Visual Means (OAVM) at the registered office in Bengaluru, Karnataka.

The agenda includes the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026. Shareholders will vote on the re-appointment of directors Mrs. Jyoti Mundra and Mr. Laxminarayan Moondra, who retire by rotation. Additionally, the company seeks approval for the re-appointment of Mr. Laxminarayana Moondra as Whole Time Director for a term of 3 years effective August 20, 2026, with a revised remuneration package.

Special business includes approving related party transactions with subsidiary Natural Biogenex Private Limited. The company seeks approval to enter into contracts and provide unsecured loans up to ₹ 50 crores until the conclusion of the next AGM. The funds, sourced from internal accruals, will be utilized for future capital expenditure and meeting working capital requirements. Interest will be charged at the bank rate applicable to the company.

Shareholders will also consider revising the remuneration of Mr. Shrey Mundra, General Manager – Marketing, a related party. His gross remuneration is proposed to increase from ₹ 2,25,000 to ₹ 2,50,000 per month from April 1, 2026, and to ₹ 2,75,000 per month thereafter for one year. The Board has recommended these resolutions, with the re-appointment of the Whole Time Director requiring a special resolution and other items requiring ordinary resolutions.

Remote e-voting will commence on August 8, 2026, at 09:00 AM and conclude on August 11, 2026, at 05:00 PM. Members can cast votes electronically through the NSDL e-voting system. The facility for attending the AGM via VC/OAVM is available on a first-come-first-served basis for 1,000 members, excluding large shareholders holding more than 2% of shares and institutional investors.

Key AGM Dates

Natural Biogenex Private Limited, a material unlisted subsidiary of natural capsules , has allotted 1,11,202 equity shares of ₹10 each for cash at par. The allotment aggregates to ₹11,12,020 and was approved by the board of the subsidiary on July 10, 2026. The rights issue was previously approved by the board on May 27, 2026.

Allotment Details

The board of Natural Biogenex Private Limited approved the allotment of the rights issue shares during its meeting held on July 10, 2026. The shares were issued for cash at par, with the total amount aggregating to ₹11,12,020.

The intimation regarding the allotment was submitted to BSE Limited and National Stock Exchange of India Limited under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.